While the technology remains investigational in many practices, researchers say it has the potential to improve diagnostic accuracy, streamline AI development and strengthen radiology quality assurance.
Radiologist Henry C. Lusane, MD, with Acumen Medical Imaging, interpreted the scans, reporting the mass as benign, a mistake later leading to a terminal cancer diagnosis.
The Women’s Center for Radiology, which was acquired by Solis Mammography in January, hired a cybersecurity firm to help investigate the scope of the matter.
John Simon, MD, is a big advocate for these elective exams, but the American College of Radiology and some members of the specialty oppose this practice.
The “Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio” test is indicated for the early detection of amyloid plaques, a hallmark sign of the neurodegenerative disease.
